About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: May 4, 2006
Statins and The RX to OTC Switch Pipeline
As mentioned yesterday, the increase in the number of patent expirations set for the next few years indicates an opportunity for an increase in RX to OTC switches. In March, I had a posting on the challenges in the current … Continue reading
Posted in OTC Switches
3 Comments